Matulac, Rogelio B.
HRN: 22-02-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
MUPIROCIN 2%, 15G (TUBE)
10/30/2022
11/05/2022
TOPICAL
1mg
BID
Bed Sores And Superficial Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes